Important funding for nanomedicine research to improve diagnosis and treatment - Photo Gallery
Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced on March 16th, 2011 at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto.
Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Dr. Shana Kelley, University of Toronto; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto.
Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis.
Dr. Shana Kelley, University of Toronto, gives a tour of the research lab.
Dr. Shana Kelley, University of Toronto
Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto.
Dr. Colin Carrie, Member of Parliament for Oshawa.
Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency.
Supplemental content (right column)
- Modified: